Suppr超能文献

经皮给药的化学渗透增强剂的虚拟设计。

Virtual design of chemical penetration enhancers for transdermal drug delivery.

机构信息

School of Chemical Engineering, Oklahoma State University, Stillwater, OK, USA.

出版信息

Chem Biol Drug Des. 2012 Apr;79(4):478-87. doi: 10.1111/j.1747-0285.2011.01293.x.

Abstract

Traditional drug design is a laborious and expensive process that often challenges the pharmaceutical industries. As a result, researchers have turned to computational methods for computer-assisted molecular design. Recently, genetic and evolutionary algorithms have emerged as efficient methods in solving combinatorial problems associated with computer-aided molecular design. Further, combining genetic algorithms with quantitative structure-property relationship analyses has proved effective in drug design. In this work, we have integrated a new genetic algorithm and nonlinear quantitative structure-property relationship models to develop a reliable virtual screening algorithm for the generation of potential chemical penetration enhancers. The genetic algorithms-quantitative structure-property relationship algorithm has been implemented successfully to identify potential chemical penetration enhancers for transdermal drug delivery of insulin. Validation of the newly identified chemical penetration enhancer molecular structures was conducted through carefully designed experiments, which elucidated the cytotoxicity and permeability of the chemical penetration enhancers.

摘要

传统的药物设计是一个费力且昂贵的过程,这常常给制药行业带来挑战。因此,研究人员转向了计算方法,以进行计算机辅助分子设计。最近,遗传和进化算法已成为解决与计算机辅助分子设计相关的组合问题的有效方法。此外,将遗传算法与定量构效关系分析相结合,已被证明在药物设计中是有效的。在这项工作中,我们整合了一种新的遗传算法和非线性定量构效关系模型,以开发一种可靠的虚拟筛选算法,用于生成潜在的化学渗透增强剂。遗传算法-定量构效关系算法已成功实施,以确定胰岛素经皮给药的潜在化学渗透增强剂。通过精心设计的实验对新鉴定的化学渗透增强剂分子结构进行了验证,阐明了化学渗透增强剂的细胞毒性和渗透性。

相似文献

1
Virtual design of chemical penetration enhancers for transdermal drug delivery.
Chem Biol Drug Des. 2012 Apr;79(4):478-87. doi: 10.1111/j.1747-0285.2011.01293.x.
2
Design of improved permeation enhancers for transdermal drug delivery.
J Pharm Sci. 2009 Nov;98(11):4085-99. doi: 10.1002/jps.21940.
3
A skin permeability model of insulin in the presence of chemical penetration enhancer.
Int J Pharm. 2010 Mar 30;388(1-2):13-23. doi: 10.1016/j.ijpharm.2009.12.028. Epub 2009 Dec 21.
4
Permeation enhancers in transdermal drug delivery: benefits and limitations.
Expert Opin Drug Deliv. 2020 Feb;17(2):145-155. doi: 10.1080/17425247.2020.1713087. Epub 2020 Jan 14.
5
Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
J Pharm Sci. 2016 Mar;105(3):1134-40. doi: 10.1016/S0022-3549(15)00172-0. Epub 2016 Jan 25.
6
Role of complexes formation between drugs and penetration enhancers in transdermal delivery.
Int J Pharm. 2008 Nov 3;363(1-2):40-9. doi: 10.1016/j.ijpharm.2008.06.032. Epub 2008 Jul 12.
7
Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
J Pharm Pharmacol. 2015 Apr;67(4):473-85. doi: 10.1111/jphp.12334. Epub 2014 Dec 31.
8
Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery.
Pharm Dev Technol. 2017 Jun;22(4):511-520. doi: 10.3109/10837450.2015.1131718. Epub 2016 Jan 13.
9
Discovery of transdermal penetration enhancers by high-throughput screening.
Nat Biotechnol. 2004 Feb;22(2):192-7. doi: 10.1038/nbt928. Epub 2004 Jan 4.
10
Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
Curr Drug Deliv. 2015;12(6):645-51. doi: 10.2174/1567201812666150804104600.

引用本文的文献

1
Unraveling the Potential of Vitamin B-Derived Salts with a Salicylate Anion as Dermal Active Agents for Acne Treatment.
Mol Pharm. 2024 Sep 2;21(9):4634-4647. doi: 10.1021/acs.molpharmaceut.4c00543. Epub 2024 Aug 14.
2
Current Development of Chemical Penetration Enhancers for Transdermal Insulin Delivery.
Biomedicines. 2023 Feb 22;11(3):664. doi: 10.3390/biomedicines11030664.
3
Amorphization of Drugs for Transdermal Delivery-a Recent Update.
Pharmaceutics. 2022 May 3;14(5):983. doi: 10.3390/pharmaceutics14050983.
4
Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks.
Turk J Pharm Sci. 2017 Dec;14(3):213-221. doi: 10.4274/tjps.97720. Epub 2017 Nov 20.
5
Optical clearing of skin enhanced with hyaluronic acid for increased contrast of optoacoustic imaging.
J Biomed Opt. 2016 Aug;21(8):081208. doi: 10.1117/1.JBO.21.8.081208.
6
Computational methods in drug discovery.
Pharmacol Rev. 2013 Dec 31;66(1):334-95. doi: 10.1124/pr.112.007336. Print 2014.
7
Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
Molecules. 2013 Jan 8;18(1):735-56. doi: 10.3390/molecules18010735.

本文引用的文献

1
Effect of different enhancers on the transdermal permeation of insulin analog.
Int J Pharm. 2010 Oct 15;398(1-2):83-92. doi: 10.1016/j.ijpharm.2010.07.029. Epub 2010 Aug 3.
2
A skin permeability model of insulin in the presence of chemical penetration enhancer.
Int J Pharm. 2010 Mar 30;388(1-2):13-23. doi: 10.1016/j.ijpharm.2009.12.028. Epub 2009 Dec 21.
3
Design of improved permeation enhancers for transdermal drug delivery.
J Pharm Sci. 2009 Nov;98(11):4085-99. doi: 10.1002/jps.21940.
5
Quantitative structure-property relationship modeling of skin sensitization: a quantitative prediction.
Toxicol In Vitro. 2009 Apr;23(3):454-65. doi: 10.1016/j.tiv.2008.12.025. Epub 2009 Jan 8.
6
Quantitative structure-property relationships modeling of skin irritation.
Toxicol In Vitro. 2009 Feb;23(1):176-84. doi: 10.1016/j.tiv.2008.10.013. Epub 2008 Nov 5.
7
Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin.
Pharm Res. 2008 Nov;25(11):2697-704. doi: 10.1007/s11095-008-9696-y. Epub 2008 Aug 6.
8
Percutaneous penetration enhancers: an overview.
Skin Pharmacol Physiol. 2007;20(6):272-82. doi: 10.1159/000107575. Epub 2007 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验